International Clinical Trial: A Single-arm, Single-center, Phase II Prospective Clinical Study on the Efficacy and Safety of Low-dose Radiotherapy Combined with Immuno-chemotherapy for Local Advanced Potential/Border Resectable Esophageal Squamous Cell Carcinoma (ESCC-LDR-02)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115140) titled 'A Single-arm, Single-center, Phase II Prospective Clinical Study on the Efficacy and Safety of Low-dose Radiotherapy Combined with Immuno-chemotherapy for Local Advanced Potential/Border Resectable Esophageal Squamous Cell Carcinoma (ESCC-LDR-02)' on Dec. 23, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Army Medical Center of PLA

Condition: patients with locally advanced esophageal squamous cell carcinoma who are potentially or marginally resectable

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-01-01

Target Sample Size: Low-dose radiothe...